November 12, 2014
WILMINGTON, N.C. – Quintiles has
renewed its title sponsorship of the Wrightsville Beach Marathon for the next
three years, it was announced today. The 6th annual Quintiles
Wrightsville Beach Marathon presented by Landfall Realty will take place March 22,
2015.
The North Carolina based biopharmaceutical services
company has been the title sponsor of the award-winning event since its
inception in 2009. “We’re proud to
have our name associated with such a great event,” said Steve Brechbiel, senior
director, community relations at Quintiles. “Every year, our participants and their families tell us
this is one of the best in the region.
Our title sponsorship is a visible reminder of Quintiles’ global
leadership position in biopharmaceutical services as we contribute to a
healthier world.”
The Quintiles Wrightsville Beach Marathon Madness
Weekend brings 4,000 runners and their families to the Wilmington area each
year and generates an estimated $3 million in economic impact. Events include a marathon,
half marathon, relay, 5K, and 1-mile fun run. The 2015 half marathon will serve as the North Carolina USA
Track and Field Championship and a qualifier for the New York City Half
Marathon. The full marathon is a
qualifier for the Boston Marathon and New York City Marathon.
“We are honored to continue this growing tradition
with Quintiles,” said Tom Clifford, event director. “Going into our 6th year it is clear that
participants recognize this race as the Quintiles race over any other name,
which says a lot about the value of our partnership.”
Help Get Sponsors, a full-service sponsorship sales
and management company based in Raleigh, N.C., secured the deal on behalf of
its client, the Quintiles Wrightsville Beach Marathon.
About Quintiles
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
